{"disease":{"id":"bone-metastatic-castration-resistant-prostate-cancer","name":"bone metastatic castration resistant prostate cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04587427","title":"A Study to Learn More About How Radium-223 is Being Used With Other Treatments in European Patients Who Have Not Received Radium-223 Before","phase":"","overall_status":"COMPLETED","enrollment_count":1067,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04521361","title":"A Study to Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the Bones","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT02204943","title":"Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Duke University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}